Fatigue News and Research

RSS

Ingredient in cough medicine could treat prostate cancer

A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.

22 Dec 2008

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.

21 Dec 2008

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.

18 Dec 2008

Spending time in nature keeps supresses mental fatigue

If you spend the majority of your time among stores, restaurants and skyscrapers, it may be time to trade in your stilettos for some hiking boots.

18 Dec 2008

Sleep-related breathing disorders linked to calories burned at rest

Individuals with sleep-related breathing disorders appear to burn more calories when resting as their conditions become more severe, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery.

15 Dec 2008

Cymbalta (duloxetine HCl) shown to delay new episodes of depression

New data suggest that Cymbalta (duloxetine HCl) 60 mg to 120 mg once daily delayed the onset of a new episode of depression in patients who had previously responded to the medication and who had recurrent depressive disorder, defined in the study as those patients who experienced at least three depressive episodes in the previous five years, compared with placebo (p < .001).

14 Dec 2008

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Results from a Phase 3 study show that patients with metastatic breast cancer who were treated previously with an anthracycline in the adjuvant setting experienced a significant improvement in time to disease progression (TTP) and overall response rates after receiving a combination of DOXIL (doxorubicin HCl liposome injection) and docetaxel as compared to docetaxel alone.

14 Dec 2008

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.

14 Dec 2008

Australians warned of rabies outbreak in Bali

The warning comes from the head of the Northern Territory's Centre for Disease Control, Dr. Peter Markey, who says anyone bitten or scratched on the island by an animal should seek medical advice; the warning also applies to people who have been to Bali recently.

14 Dec 2008

Weights better than aerobic training for back pain

People who use weight training to ease their lower back pain are better off than those who choose other forms of exercise such as jogging, according to a University of Alberta study.

12 Dec 2008

Novavax announces positive results in trial of seasonal influenza VLP (trivalent) vaccine candidate

Novavax, Inc. has announced favorable results from a Phase IIa human clinical trial of its seasonal influenza VLP (trivalent) vaccine candidate.

12 Dec 2008

$Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma$

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

10 Dec 2008

New data on ZOLINZA (vorinostat) in combination with Bortezomib

Results from two Phase 1 studies of ZOLINZA (vorinostat), Merck's oral histone deacetylase (HDAC) inhibitor, administered in combination with bortezomib, showed early anti-tumor activity in patients with relapsed and/or refractory multiple myeloma, including those previously treated with and no longer responding to bortezomib.

10 Dec 2008

Dacogen data presented on trial in seniors with acute myeloid leukemia

Eisai Corporation of North America has announced data from a Phase II trial evaluating a five-day dosing regimen of Dacogen(R) (decitabine for injection) in acute myeloid leukemia (AML), the most common form of leukemia.

10 Dec 2008

FDA announces permanent injunction against Wilderness Family Naturals

The U.S. Food and Drug Administration has announced that Wilderness Family Naturals LLC of Silver Bay, Minn., and its owners have signed a consent decree that prohibits them from manufacturing and distributing any products with unapproved claims that the products cure, treat, mitigate or prevent diseases.

10 Dec 2008

Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

Startling findings from a new CML (chronic myelogenous leukemia) patient survey were presented at a satellite meeting of the American Society of Hematology annual meeting, in San Francisco.

8 Dec 2008

Treatment fails to improve common form of heart failure

A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.

5 Dec 2008

Study finds medication fails to improve common form of heart failure

A medication used for high blood pressure does not improve a common form of heart failure, according to new results from a large, international study.

5 Dec 2008

New recommendations on late-onset hypogonadism

The January issue of European Urology, the official journal of the European Association of Urology published by Elsevier, will feature new recommendations on late-onset hypogonadism (LOH), recently formulated by major scientific organizations.

5 Dec 2008

Interferon as long-term treatment for hepatitis C not effective

Use of the drug interferon as a long-term maintenance strategy to slow the progression of liver disease associated with the hepatitis C virus is ineffective, UT Southwestern Medical Center researchers and their colleagues from nine other institutions have found in a multicenter study.

5 Dec 2008

Fatigue News and Research

Ingredient in cough medicine could treat prostate cancer

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

Spending time in nature keeps supresses mental fatigue

Sleep-related breathing disorders linked to calories burned at rest

Cymbalta (duloxetine HCl) shown to delay new episodes of depression

Doxil and docetaxel combination treatment delays disease progression in metastatic breast cancer

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

Australians warned of rabies outbreak in Bali

Weights better than aerobic training for back pain

Novavax announces positive results in trial of seasonal influenza VLP (trivalent) vaccine candidate

Proteolix announces positive data for carfilzomib in patients with relapsed and refractory multiple myeloma

New data on ZOLINZA (vorinostat) in combination with Bortezomib

Dacogen data presented on trial in seniors with acute myeloid leukemia

FDA announces permanent injunction against Wilderness Family Naturals

Chronic myelogenous leukemia patient survey shows that side effects are a serious issue

Treatment fails to improve common form of heart failure

Study finds medication fails to improve common form of heart failure

New recommendations on late-onset hypogonadism

Interferon as long-term treatment for hepatitis C not effective

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News